Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles:

Simon Y. Graeber, Diane M. Renz, Mirjam Stahl, Sophia T. Pallenberg, Olaf Sommerburg, Lutz Naehrlich, Julian Berges, Martha Dohna, Felix C. Ringshausen, Felix Doellinger, Constanze Vitzthum, Jobst Röhmel, Christine Allomba, Susanne Hämmerling, Sandra Barth, Claudia Rückes-Nilges, Mark O. Wielpütz, Gesine Hansen, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall, and Anna-Maria Dittrich

10 May, 2022

NZ Respiratory Research Review Issue 203

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study:

Eric D. Bateman, David B. Price, Hao-Chien Wang, Adel Khattab, Patricia Schonffeldt, Angelina Catanzariti, Ralf J.P. van der Valk, Maarten J.H.I. Beekman

5 May, 2022

NZ Respiratory Research Review Issue 200

Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease:

Charlotte Rigauts, Juliana Aizawa, Steven L. Taylor, Geraint B. Rogers, Matthias Govaerts, Paul Cos, Lisa Ostyn, Sarah Sims, Eva Vandeplassche, Mozes Sze, Yves Dondelinger, Lars Vereecke, Heleen Van Acker, Jodie L. Simpson, Lucy Burr, Anne Willems, Michael M. Tunney, Cristina Cigana, Alessandra Bragonzi, Tom Coenye and Aurélie Crabbé

5 May, 2022

NZ Respiratory Research Review Issue 204

Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials:

Yunus Çolak, Børge G. Nordestgaard, Peter Lange, Jørgen Vestbo, and Shoaib Afzal

19 April, 2022

NZ Respiratory Research Review Issue 204

Prognosis of Patients with COPD Not Eligible for Major Clinical Trials:

Yunus Çolak; Børge G Nordestgaard; Peter Lange; Jørgen Vestbo; Shoaib Afzal

18 April, 2022

NZ Respiratory Research Review Issue 198

Evaluating Prediction Models of Sleep Apnea From Smartphone-Recorded Sleep Breathing Sounds:

Sung-Woo Cho, MD; Sung Jae Jung, PhD; Jin Ho Shin, MS; et al

14 April, 2022

NZ Respiratory Research Review Issue 197

Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator - A Randomized Clinical Trial:

Chantal E. Atwood, PhD Mohit Bhutani, MD Maria B. Ospina, PhD Brian H. Rowe, MD Richard Leigh, MD Lesly Deuchar, MN Peter Faris, PhD Marta Michas, PhD Kelly J. Mrklas, PhD Jim Graham, RN Raymond Aceron, NP Ron Damant, MD Lee Green, MD Naushad Hirani, MD Kelly Longard, RN Virginia Meyer, MBA Patrick Mitchell, MD Willis Tsai, MD Brandie Walker, MD Michael K. Stickland, PhD

8 April, 2022

NZ Respiratory Research Review Issue 204

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis:

Jonathan R Baker, PhD Mahdi Mahdi, BSc Dan V Nicolau Jr, PhD Sanjay Ramakrishnan, MBBS Prof Peter J Barnes, FRS Jodie L Simpson, PhD et al.

7 April, 2022

NZ Respiratory Research Review Issue 200

No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event:

Maxime Delrue, MD, PhD Alain Stépanian, PhD Sebastian Voicu, MD, PhD Kladoum Nassarmadji, MD Damien Sène, MD, PhD Philippe Bonnin, MD, PhD Jean-Philippe Kevorkian, MD, PhD Pierre-Olivier Sellier, MD, PhD Jean-Michel Molina, MD, PhD Marie Neuwirth, MD Dominique Vodovar, MD, PhD Stéphane Mouly, MD, PhD Alexandre Mebazaa, MD, PhD Bruno Mégarbane, MD, PhD Virginie Siguret, PhD

6 April, 2022

NZ Respiratory Research Review Issue 202

Real-world opioid prescription to patients with serious, non-malignant, respiratory illnesses and chronic breathlessness:

Xinye Chen,Thomas Moran,Natasha Smallwood

5 April, 2022

NZ Respiratory Research Review Issue 198